查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
2023-2030 年临床试验生物储存库和存檔解决方案市场规模、份额、趋势分析报告（按服务（存檔解决方案、生物储存服务）、副产品（临床前、临床）、阶段（II、III）、分部预测）
市场调查报告书
商品编码
1233157

2023-2030 年临床试验生物储存库和存檔解决方案市场规模、份额、趋势分析报告（按服务（存檔解决方案、生物储存服务）、副产品（临床前、临床）、阶段（II、III）、分部预测）

Clinical Trial Biorepository & Archiving Solutions Market Size, Share & Trends Analysis Report By Service (Archiving Solution, Biorepository Services), By Product (Preclinical, Clinical), By Phase (II, III), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

临床试验生物样本库和存檔解决方案的市场增长和趋势

根据 Grand View Research, Inc. 的一份新报告，全球临床试验生物样本库和归檔解决方案市场规模从 2023 年到 2030 年的复合年增长率将达到 8.3%，预计2030 年将达到 70 亿美元。

这主要是由于生物样本管理在临床试验中的重要性与日俱增，并且需要更高效的数据收集和报告。 此外，随着精准医学、个性化医学和基因组医学的扩展，研发支出的增加，采用实验室资讯管理系统（LIMS）等软件来管理实验室样本有助于数据收集和报告。努力促进行业的发展是推动行业发展的主要因素。

多个监管机构建议并製定运营生物样本库的最佳实践。 国际生物环境储存协会正在加强其在全球范围内标准化生物储存程序的地位。 美国病理学家协会建立了第一个符合严格法规的生物样本库认证计划，以标准化生物样本库实践。 国际标准化组织 (ISO-20387) 已经发布了关于生物保存能力、公正性和一致性操作的生物储存库标准。

美国FDA制定了GMP（良好生产规范）、GLP（良好实验室规范）、GDP和GTP（良好组织规范），其中包括与药品包装和储存相关的要素。 COVID-19 大流行还为当地企业创造了多个增长机会。 为了巩固在行业中的立足点，各大公司正在采取各种计划和政策，以在全球市场上获得更大的收入份额。 领先公司已将与相关第三方供应商的合作确定为关键步骤。 这可以通过适当沟通和协调临床试验生物储存库和存檔解决方案的频率和数量来实现。

临床试验生物储存库和存檔解决方案市场报告要点

  • 个性化医疗等先进疗法的研发增加，以及对用于样本采集、处理、测试和存储的高质量生物样本库实践的需求，导致生物样本库服务领域在 2022 年占据行业主导地位。
  • 按阶段划分，III 期细分市场预计将在 2022 年主导行业，而 II 期细分市场预计将在 2023 年至 2030 年实现最快的复合年增长率。
  • 临床产品部分将在 2022 年占据最大份额，因为大多数临床试验方案严重依赖生物样本分析来满足试验终点。
  • 预计亚太地区在预测期内的增长率最快。 临床试验地点从欧洲和北美等西方地区向亚太地区转移是该地区的主要促进因素。

内容

第 1 章调查方法及范围

  • 市场细分和范围
    • 服务
    • 阶段
    • 产品类型
    • 区域范围
  • 调查方法
  • 资讯采购
    • 购买的数据库
    • GVR 内部数据库
    • 次要资讯
    • 初步调查
    • 初步调查的内容
  • 资讯或数据分析
    • 数据分析模型
  • 市场製定和验证
  • 模型详细资讯
    • 商品流分析（模型 1）
  • 二级资讯列表
  • 缩写列表
  • 目的

第 2 章执行摘要

  • 市场概况
  • 片段快照
  • 竞争格局快照

第 3 章临床试验生物储存库和存檔解决方案市场：变量、趋势和范围

  • 市场系列展望
    • 母公司市场展望
    • 辅助市场展望
  • 描绘渗透率和增长前景
  • 市场动态
    • 市场促进因素分析
      • 增加製药和生物技术公司
      • 疾病变异和患病率增加
      • 增加研发投资
      • CRO 市场增长
    • 市场抑制因素分析
      • 新药开发法规
      • 临床试验成本上升
  • 临床试验生物储存库和存檔解决方案市场分析工具
    • 波特的五力分析
    • PESTEL 分析
  • 主要交易和战略联盟
  • COVID-19 的影响

第 4 章临床试验生物资源库和存檔解决方案市场：服务细分分析

  • 定义和范围
  • 临床试验生物样本库和存檔解决方案：2022 年和 2030 年市场份额分析
  • 生物样本库服务
    • 仓库存储
    • 交通
    • 样品处理
    • 其他
  • 归檔解决方案服务
    • 数据库索引和管理
    • 扫描并销毁

第 5 章临床试验生物资源库和存檔解决方案市场：产品类型细分分析

  • 定义和范围
  • 临床试验生物样本库和存檔解决方案：2022 年和 2030 年市场份额分析
  • 临床前产品
  • 临床产品
    • 人体组织
    • 器官
    • 干细胞
    • 其他生物样本

第 6 章临床试验生物储存库和存檔解决方案市场：阶段细分分析

  • 定义和范围
  • 临床试验生物样本库和存檔解决方案：2022 年和 2030 年市场份额分析
  • 第一阶段
  • 第二阶段
  • 第三阶段
  • 第四阶段

第 7 章临床试验生物储存库和存檔解决方案市场：区域分析

  • 临床试验生物样本库和存檔解决方案：2022 年和 2030 年市场份额分析
  • 北美
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 意大利
    • 西班牙
    • 瑞典
    • 丹麦
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
  • 多边环境协定
    • 南非
    • 沙特阿拉伯
    • 阿拉伯联合酋长国
    • 科威特

第 8 章竞争格局

  • 公司简介
    • Medpace
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • ATCC
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Cell&co BioServices
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Azenta US, Inc.
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Thermo Fisher Scientific Inc.（Patheon）
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Precision Medicine Group, LLC.
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Labcorp Drug Development
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Q2 Solutions
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • LabConnect
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
    • Charles River Laboratories
      • 公司简介
      • 财务业绩
      • 服务基准
      • 战略举措
Product Code: GVR-4-68039-532-8

Clinical Trial Biorepository & Archiving Solutions Market Growth & Trends:

The global clinical trial biorepository & archiving solutions market size is expected to reach USD 7.0 billion by 2030, registering a CAGR of 8.3%, from 2023 to 2030, according to a new report by Grand View Research, Inc. This is mainly due to the increasing importance of biological sample management in clinical trials and the desire to streamline data collection and reporting. In addition, the expansion of precision, personalized, and genomic medicine, increased R&D spending and efforts to make data gathering & reporting easier by employing software like the Laboratory Information Management System (LIMS) to manage laboratory samples are all key factors driving the industry growth.

Multiple regulatory agencies advise and develop best practices in biorepository operations. The International Society for Biological and Environmental Repositories has strengthened its position in the standardization of bio-storage procedures on a global level. The College of American Pathologists established the first biorepository accreditation scheme that adheres to stringent regulations to standardize biorepository practices. Biorepository standards for competence, impartiality, and consistent operation for bio storage have been issued by the International Organization for Standardization (ISO-20387).

The U.S. FDA has established Good Manufacturing Practice (GMP), Good Laboratory Practice (GLP), GDP, and Good Tissue Practice (GTP), which contain the elements associated with the packing and storage of drug products. In addition, the COVID-19 pandemic has created several growth opportunities for local companies. To enhance their foothold in the industry, key companies are adopting various plans and policies to gain a more significant revenue share in the global market. The important step key players can incorporate partnering with relevant third-party vendors. It can be achieved through proper communication and adjustments in the frequency and volume of clinical trial biorepository and archiving solutions.

Clinical Trial Biorepository & Archiving Solutions Market Report Highlights:

  • The biorepository services segment dominated the industry in 2022 due to the rise in R&D of advanced therapies, such as personalized medicine, and the requirement of high-quality biorepository practices for the collection, processing, testing, and storage of samples
  • In terms of phase, the phase III segment dominated the industry in 2022 while the phase II segment is estimated to register the fastest CAGR from 2023 to 2030
  • The clinical products segment held the largest share in 2022 as most clinical trial protocols depend largely on the analysis of biological specimens to meet the study endpoints
  • Asia Pacific is anticipated to register the fastest growth rate over the forecast period. The shift of clinical trial sites from Western regions, such as Europe and North America, to Asia Pacific is a major factor driving the region

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Service
    • 1.1.2 Phase
    • 1.1.3 Product Type
    • 1.1.4 Regional scope
    • 1.1.5 Estimates and forecast timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR'S internal database
    • 1.3.3 Secondary sources
    • 1.3.4 Primary research
    • 1.3.5 Details of primary research
  • 1.4 Information or Data Analysis
    • 1.4.1 Data analysis models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity flow analysis (Model 1)
  • 1.7 List of Secondary Sources
  • 1.8 List of Abbreviations
  • 1.9 Objectives
    • 1.9.1 Objective - 1
    • 1.9.2 Objective - 2
    • 1.9.3 Objective - 3
    • 1.9.4 Objective - 4

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Clinical Trial Biorepository & Archiving Solutions Market: Variables, Trends, & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Market Dynamics
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Growing number of pharmaceutical and biotechnology companies
      • 3.3.1.2 Growing disease variation and prevalence
      • 3.3.1.3 Increasing R&D investments
      • 3.3.1.4 Growth in the CRO market
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Regulations in new drug development
      • 3.3.2.2 Rising cost of clinical trials
  • 3.4 Clinical Trial Biorepository & Archiving Solutions Market Analysis Tools
    • 3.4.1 Porter's Five Forces analysis
    • 3.4.2 PESTEL analysis
  • 3.5 Major Deals & Strategic Alliances
  • 3.6 Covid-19 Impact

Chapter 4 Clinical Trial Biorepository & Archiving Solutions Market: Service Segment Analysis

  • 4.1 Definitions & Scope
  • 4.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 4.3 Biorepository Services
    • 4.3.1 Biorepository services market, 2018 - 2030 (USD Million)
    • 4.3.2 Warehousing & storage
      • 4.3.2.1 Warehousing & storage market, 2018 - 2030 (USD Million)
    • 4.3.3 Transportation
      • 4.3.3.1 Transportation market, 2018 - 2030 (USD Million)
    • 4.3.4 Sample Processing
      • 4.3.4.1 Sample Processing market, 2018 - 2030 (USD Million)
    • 4.3.5 Others
      • 4.3.5.1 Others market, 2018 - 2030 (USD Million)
  • 4.4 Archiving Solution Services
    • 4.4.1 Archiving Solution Services market, 2018 - 2030 (USD Million)
    • 4.4.2 Database Indexing and Management
      • 4.4.2.1 Database Indexing and Management market, 2018 - 2030 (USD Million)
    • 4.4.3 Scanning & Destruction
      • 4.4.3.1 Scanning & Destruction, 2018 - 2030 (USD Million)

Chapter 5 Clinical Trial Biorepository & Archiving Solutions Market: Product Type Segment Analysis

  • 5.1 Definitions & Scope
  • 5.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 5.3 Preclinical Products
    • 5.3.1 Preclinical ProductsMarket, 2018 - 2030 (USD Million)
  • 5.4 Clinical Products
    • 5.4.1 Clinical Products market, 2018 - 2030 (USD Million)
    • 5.4.2 Human Tissue
      • 5.4.2.1 Human Tissue market, 2018 - 2030 (USD Million)
    • 5.4.3 Organs
      • 5.4.3.1 Organs market, 2018 - 2030 (USD Million)
    • 5.4.4 Stem cells
      • 5.4.4.1 Stem cells market, 2018 - 2030 (USD Million)
    • 5.4.5 Other biospecimens
      • 5.4.5.1 Other biospecimens market, 2018 - 2030 (USD Million)

Chapter 6 Clinical Trial Biorepository & Archiving Solutions Market: Phase Segment Analysis

  • 6.1 Definitions & Scope
  • 6.2 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 6.3 Phase I
    • 6.2.1 Phase I Market, 2018 - 2030 (USD Million)
  • 6.4 Phase II
    • 6.3.1 Phase II market, 2018 - 2030 (USD Million)
  • 6.5 Phase III
    • 6.4.1 Phase III market, 2018 - 2030 (USD Million)
  • 6.6 Phase IV
    • 6.5.1 Phase IV market, 2018 - 2030 (USD Million)

Chapter 7 Clinical Trial Biorepository & Archiving Solutions Market: Regional Analysis

  • 7.1 Clinical Trial Biorepository & Archiving Solutions: Market Share Analysis, 2022 & 2030
  • 7.2 North America
    • 7.2.1 North America clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.2.2 U.S.
      • 7.2.2.1 U.S. clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.2.3 Canada
      • 7.2.3.1 Canada clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.3 Europe
    • 7.3.1 Europe clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.2 U.K.
      • 7.3.2.1 U.K. clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.3 Germany
      • 7.3.3.1 Germany clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.4 France
      • 7.3.4.1 France clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.5 Italy
      • 7.3.5.1 Italy clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.6 Spain
      • 7.3.6.1 Spain clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.7 Sweden
      • 7.3.7.1 Sweden clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.8 Denmark
      • 7.3.8.1 Denmark clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.3.9 Norway
      • 7.3.9.1 Norway clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.4 Asia Pacific
    • 7.4.1 Asia Pacific clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.2 Japan
      • 7.4.2.1 Japan clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.3 China
      • 7.4.3.1 China clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.4 India
      • 7.4.4.1 India clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.5 Australia
      • 7.4.5.1 Australia clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.6 South Korea
      • 7.4.6.1 South Korea clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.4.7 Thailand
      • 7.4.7.1 Thailand clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.5 Latin America
    • 7.5.1 Latin America clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.2 Brazil
      • 7.5.2.1 Brazil clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.3 Mexico
      • 7.5.3.1 Mexico clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.4 Argentina
      • 7.5.4.1 Argentina clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.5.5 Colombia
      • 7.5.5.1 Colombia clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
  • 7.6 MEA
    • 7.6.1 MEA clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.2 South Africa
      • 7.6.2.1 South Africa clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.3 Saudi Arabia
      • 7.6.3.1 Saudi Arabia clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.4 UAE
      • 7.6.4.1 UAE clinical trial biorepository & archiving solutions market, 2018 - 2030 (USD Million)
    • 7.6.5 Kuwait

Chapter 8 Competitive Landscape

  • 8.1 Company Profiles
    • 8.1.1 Medpace
      • 8.1.1.1 Company overview
      • 8.1.1.2 Financial performance
      • 8.1.1.3 Service benchmarking
      • 8.1.1.4 Strategic Initiatives
    • 8.1.2 ATCC
      • 8.1.2.1 Company overview
      • 8.1.2.2 Financial performance
      • 8.1.2.3 Service benchmarking
      • 8.1.2.4 Strategic Initiatives
    • 8.1.3 Cell&co BioServices
      • 8.1.3.1 Company overview
      • 8.1.3.2 Financial performance
      • 8.1.3.3 Service benchmarking
      • 8.1.3.4 Strategic Initiatives
    • 8.1.4 Azenta US, Inc.
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Service benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.5 Thermo Fisher Scientific Inc. (Patheon)
      • 8.1.4.1 Company overview
      • 8.1.4.2 Financial performance
      • 8.1.4.3 Service benchmarking
      • 8.1.4.4 Strategic Initiatives
    • 8.1.6 Precision Medicine Group, LLC.
      • 8.1.6.1 Company overview
      • 8.1.6.2 Financial performance
      • 8.1.6.3 Service benchmarking
      • 8.1.6.4 Strategic Initiatives
    • 8.1.7 Labcorp Drug Development
      • 8.1.7.1 Company overview
      • 8.1.7.2 Financial performance
      • 8.1.7.3 Service benchmarking
      • 8.1.7.4 Strategic Initiatives
    • 8.1.8 Q2 Solutions
      • 8.1.8.1 Company overview
      • 8.1.8.2 Financial performance
      • 8.1.8.3 Service benchmarking
      • 8.1.8.4 Strategic Initiatives
    • 8.1.9 LabConnect
      • 8.1.9.1 Company overview
      • 8.1.9.2 Financial performance
      • 8.1.9.3 Service benchmarking
      • 8.1.9.4 Strategic Initiatives
    • 8.1.10 Charles River Laboratories
      • 8.1.10.1 Company overview
      • 8.1.10.2 Financial performance
      • 8.1.10.3 Service benchmarking
      • 8.1.10.4 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information procurement
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Commodity flow analysis
  • Fig. 8 Clinical trial biorepository & archiving solutions market snapshot (2022)
  • Fig. 9 clinical trial biorepository & archiving solutions market segmentation
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Clinical trial biorepository & archiving solutions market service: Segment dashboard
  • Fig. 18 Clinical trial biorepository & archiving solutions market: Service movement analysis
  • Fig. 19 Biorepository services market, 2018 - 2030 (USD Million)
  • Fig. 20 Warehousing & storage market, 2018 - 2030 (USD Million)
  • Fig. 21 Transportation market, 2018 - 2030 (USD Million)
  • Fig. 22 Sample Processing market, 2018 - 2030 (USD Million)
  • Fig. 23 Others market, 2018 - 2030 (USD Million)
  • Fig. 24 Archiving solution services market, 2018 - 2030 (USD Million)
  • Fig. 25 Database indexing and management market, 2018 - 2030 (USD Million)
  • Fig. 26 Scanning & destruction market, 2018 - 2030 (USD Million)
  • Fig. 27 Clinical trial biorepository & archiving solutions market product type outlook: Segment dashboard
  • Fig. 28 Clinical trial biorepository & archiving solutions market: Product type movement analysis
  • Fig. 29 Preclinical products market, 2018 - 2030 (USD Million)
  • Fig. 30 Clinical products market, 2018 - 2030 (USD Million)
  • Fig. 31 Human tissue market, 2018 - 2030 (USD Million)
  • Fig. 32 Organs market, 2018 - 2030 (USD Million)
  • Fig. 33 Stem cells market, 2018 - 2030 (USD Million)
  • Fig. 34 Other biospecimens market, 2018 - 2030 (USD Million)
  • Fig. 35 Clinical trial biorepository & archiving solutions market phase outlook: Segment dashboard
  • Fig. 36 Clinical trial biorepository & archiving solutions market: Phase movement analysis
  • Fig. 37 Phase I market, 2018 - 2030 (USD Million)
  • Fig. 38 Phase II market, 2018 - 2030 (USD Million)
  • Fig. 39 Phase III market, 2018 - 2030 (USD Million)
  • Fig. 40 Phase IV market, 2018 - 2030 (USD Million)
  • Fig. 41 Regional market: Key takeaways
  • Fig. 42 Regional outlook, 2022 2030
  • Fig. 43 North America market, 2018 - 2030 (USD Million)
  • Fig. 44 U.S. market, 2018 - 2030 (USD Million)
  • Fig. 45 Canada market, 2018 - 2030 (USD Million)
  • Fig. 46 Europe market, 2018 - 2030 (USD Million)
  • Fig. 47 U.K. market, 2018 - 2030 (USD Million)
  • Fig. 48 Germany market, 2018 - 2030 (USD Million)
  • Fig. 49 France market, 2018 - 2030 (USD Million)
  • Fig. 50 Italy market, 2018 - 2030 (USD Million)
  • Fig. 51 Spain market, 2018 - 2030 (USD Million)
  • Fig. 52 Sweden market, 2018 - 2030 (USD Million)
  • Fig. 53 Denmark market, 2018 - 2030 (USD Million)
  • Fig. 54 Norway market, 2018 - 2030 (USD Million)
  • Fig. 55 Asia Pacific market, 2018 - 2030 (USD Million)
  • Fig. 56 Japan market, 2018 - 2030 (USD Million)
  • Fig. 57 China market, 2018 - 2030 (USD Million)
  • Fig. 58 India market, 2018 - 2030 (USD Million)
  • Fig. 59 Australia market, 2018 - 2030 (USD Million)
  • Fig. 60 South Korea market, 2018 - 2030 (USD Million)
  • Fig. 61 Thailand market, 2018 - 2030 (USD Million)
  • Fig. 62 Latin America market, 2018 - 2030 (USD Million)
  • Fig. 63 Brazil market, 2018 - 2030 (USD Million)
  • Fig. 64 Mexico market, 2018 - 2030 (USD Million)
  • Fig. 65 Argentina market, 2018 - 2030 (USD Million)
  • Fig. 66 Colombia market, 2018 - 2030 (USD Million)
  • Fig. 67 MEA market, 2018 - 2030 (USD Million)
  • Fig. 68 South Africa market, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia market, 2018 - 2030 (USD Million)
  • Fig. 70 UAE market, 2018 - 2030 (USD Million)
  • Fig. 71 Kuwait market, 2018 - 2030 (USD Million)